Kaempferol’s promise in fighting triple-negative breast cancer

FHS
July 24, 2024
10:23 pm

Review highlights kaempferol’s potential in treating triple-negative breast cancer through various anticancer mechanisms and improving chemotherapeutic efficacy.

Feeling lonely? It may affect how your brain reacts to food, new research suggests

The associations between individuals’ perceived levels of social isolation and brain patterns related to food cues.

April 5, 2024

After seven patient deaths, ADC gets partial hold and decides to stop Zynlonta trial

ADC Therapeutics says it plans to stop a mid-stage study of Zynlonta in unfit or frail patients with large B cell lymphoma. The Thursday afternoon

July 22, 2023

A nation with too few pediatricians could see health care costs soar

This year’s National Residency Match, the day when medical graduates learn which health system they will do their residency programs for the next step of

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.